Skip to main content
Clinical Trials/ChiCTR1800018088
ChiCTR1800018088Not yet recruitingUnknown

CDKL3 与骨肉瘤发生发展的相关性研究及机制探讨

上海市科学技术委员会1 site in 1 country200 target enrollmentStarted: September 1, 2018Last updated:
Conditions

Trial Snapshot

Phase
Unknown
Status
Not yet recruiting
Sponsor
Enrollment
200
Locations
1
Primary Endpoint
表达水平

Study Overview

Brief Summary

大样本回顾性分析明确 CDKL3 表达与骨肉瘤临床特征及预后的相关性。

Study Design

Study Type
Observational

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 2012 年起确诊为骨肉瘤并在我院行手术治疗的病人。

Exclusion Criteria

  • Not provided

Arms & Interventions

CDKL3 高表达组

CDKL3 中表达组

CDKL3 低表达组

CDKL3 阴性

Outcomes

Primary Outcomes

表达水平

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
上海市科学技术委员会

Study Sites (1)

Loading locations...

Similar Trials